The MSL - 4 Years, 200 Episodes…What’s new, What’s not

In this milestone 200th episode, Tom Caravela welcomes Sarah Snyder to delve into the evolving landscape of the Medical Science Liaison (MSL) role. Sarah shares insights from her experience, reflecting on the changes in MSL roles, titles, and key opinion leader engagement over the past four years. The discussion covers technological advancements and recruitment trends, highlighting the growing importance of MSLs in the pharmaceutical industry. Despite the lack of standardization in roles, Sarah contrasts experiences in large versus small companies and offers predictions for the future of medical affairs. The episode concludes with reflections on the significance of MSLs and gratitude to listeners.

Sarah Snyder, MSL Recruiter with The Carolan Group discusses how the MSL role has changed in the past 4 years, and how it has not.

Learn more about…

👉 Changes in KOL Engagement and Access
👉 Titles, Responsibilities and Career Ladder
👉 Resources that have emerged for MSLs (including tech and tools)
👉 What changes in hiring practices have emerged
👉 The MSL job market and factors that have affected it
👉 The universal standard for MSLs

PLEASE sign up for the MSL Talk Podcast Newsletter here: https://www.mslmastery.com/msl-talk-podcast-newsletter-signup

The MSL Talk Podcast is available on all podcast platforms and the MSL Talk YouTube Channel. 

MSL Talk is a podcast that features helpful information for current Medical Science Liaisons, Medical Affairs leaders, job seekers looking to break into the pharmaceutical industry in their first MSL role, as well as anyone interested in hearing good industry conversation and medical affairs discussions.

#msl #medicalaffairs #medicalscienceliaison #MSLTalk #pharmaceutical

(0:00) Introduction to the 200th episode and welcoming Sarah Snyder
(2:34) Sarah Snyder's background and MSL role insights
(3:02) Sponsor: MSL Mastery
(6:02) Reflecting on changes in the MSL role over 4 years
(9:56) The evolution of MSL roles, titles, and KOL engagement
(14:59) Technological advancements for MSLs
(19:00) Trends in hiring and recruitment for MSLs
(22:56) Consistencies in the MSL role over time
(25:06) The growing significance of MSLs in the pharmaceutical industry
(28:07) Discussing the lack of standardization in MSL roles
(30:16) Comparing MSL experiences in large vs. small companies
(31:40) Predictions for the future of MSLs and medical affairs
(32:07) Closing remarks on the MSL role and thanking listeners